NPPB and hydrops fetalis: Zile et al demonstrated that patients with NT‐proBNP levels <1000 in the PARADIGM‐HF study had a significantly better prognosis compared to >1000 and had a similar risk of cardiovascular death or hospitalization as those who started with similar lower NT‐proBNP levels.21